Home › Sclerosing Cholangitis › Ohio
Sclerosing Cholangitis clinical trials in Ohio
5 studies for Sclerosing Cholangitis are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Dayton Gastroenterology- Englewood, Beavercreek
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
- Cincinnati Childrens Hospital Medical Center, Cincinnati
RecruitingObservational study
Ages 6 to 23 · All sexes · Updated Aug 19, 2026 · NCT03175471MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
- Cincinnati Children's Hospital and Medical Center, Cincinnati
RecruitingObservational study
Ages 6 to 23 · All sexes · Updated Aug 19, 2026 · NCT03178630Primary Sclerosing Cholangitis in Children
- Cincinnati Children's Hospital Medical, Cincinnati
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.